On June 1, 2021, the NMPA (National Medical Products Administration) published the list of institutions qualified for conducting clinical trials that have already completed their filing application to be listed in the NMPA database.
Since the NMPA issued the requirements and administration measures of qualified clinical trial institutions (No.145 – 2017) in November 2017, a total of 1,002 institutions have completed the filing application as of May 2021. The institutions listed in the NMPA database is currently open to public access under the website of the Center for Food and Drug Inspection in China.
By Colleen Xu. Contact Cisema if you would like to learn more.